Parallel Advisors, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1690010
SAN FRANCISCO, CA
Position in VRTX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$2,465,793
+$113,308 QoQ
Shares Held
5,522
+6.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $172,911,965 across 172 Biotechnology names. VRTX ranks #2 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
3,977,404 | $160,329,155 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
5,522 | $2,465,793 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
86,557 | $1,869,631 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,107 | $855,312 | |
| 5 | INCY |
Incyte Corp
|
4,919 | $462,976 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
14,020 | $456,210 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
1,688 | $436,044 | |
| 8 | ARGX |
Argenx SE
|
553 | $403,828 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,465,793 | 5,522 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,352,485 | 5,189 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,979,740 | 5,055 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,344,423 | 5,266 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $2,642,269 | 5,450 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $2,953,804 | 7,335 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,344,855 | 7,192 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,986,683 | 6,372 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,302,817 | 5,509 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,943,306 | 4,776 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,205,614 | 3,467 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $1,134,909 | 3,225 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $960,333 | 3,048 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $636,759 | 2,205 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $632,065 | 2,183 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $570,342 | 2,024 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $509,674 | 1,953 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $406,699 | 1,852 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $263,378 | 1,452 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $269,579 | 1,337 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $272,480 | 1,268 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $294,479 | 1,246 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $374,709 | 1,377 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $415,723 | 1,432 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $303,624 | 1,276 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||